LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Neurogene Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERNGNE
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / NGNE COVERAGE

What’s moving Neurogene Inc. now

Current reporting with the operating signal separated from the noise.

01
TradingView

Neurogene Inc. Revenue Breakdown – NASDAQ:NGNE

Investors are testing whether Neurogene Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
TradingKey

NGNE|Neurogene Inc|Price:33.490|Chg%:-0.170

The story matters when it changes Neurogene Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
TradingKey

Neurogene Inc (NGNE) Financial Health: Profitability & Balance Sheet Analysis

Investors are testing whether Neurogene Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
TradingKey

NGNE|Neurogene Inc|Price:32.815|Chg%:-0.785

The story matters when it changes Neurogene Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
TradingKey

Neurogene Inc (NGNE) Institutional Confidence

The story matters when it changes Neurogene Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest NGNE filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-12 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-13 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-24 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-02 · Period 2026-06-30SEC ↗8-KMaterial company eventFiled 2026-06-29 · Period 2026-06-29SEC ↗8-KMaterial company eventFiled 2026-06-08 · Period 2026-06-08SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-16 · Period 2026-06-03SEC ↗4Official SEC filingFiled 2026-07-07 · Period 2026-07-06SEC ↗
EARNINGS / QUARTERLY TRACKER

Neurogene Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.